8-iso- prostaglandins for glaucoma therapy
US6037368A · kind A · utility
44Cited by
11References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1998 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | May 6, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of 8-iso prostaglandins and their derivatives for decreasing intraocular pressure, for example in the treatment of glaucoma It is based, at least in part, on the discovery that 8-iso prostaglandin E.sub.2 effectively decreased intraocular pressure by a trabecular meshwork outflow mechanism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.